Weis kicks off Little Ones program
SUNBURY, Pa. Weis Markets on Monday announced the launch of its new Weis Little Ones program, allowing customers to donate diapers, baby wipes and other infant care products to babies and families in need throughout its market area.
“According to a recent study, 1-in-3 moms does not have enough diapers or other basic baby supplies to take care of her baby,” stated Karen Buch, Weis Markets director of lifestyle initiatives. “This is a particularly challenging issue. While parents in financial need may be eligible to apply for government funds through [Women, Infants and Childern] or [Supplemental Nutrition Assistance Program] to offset food and formula costs, these supplemental funds cannot be used to purchase the other essential infant care items. With the support of our customers, we will help local food banks meet this critical need.”
Customers also can make monetary donations by purchasing $1, $3 and $5 vouchers. Weis Markets will match these customers’ donations, which then will be used to purchase Huggies diapers as part of the company’s Every Little Bottom program. All donations will be forwarded to local food banks that have agreed to dispense infant care items to families in need.
The program will run in Weis Markets’ stores Oct. 17 through Nov. 27.
Huggies Every Little Bottom study of 2,000 mothers in the United States and Canada noted that families who are unable to afford an adequate supply of diapers face difficult choices. Diaper need results in babies being kept in dirty diapers for longer periods or in them wearing washed disposable diapers, which result in increased irritation and make infants more prone to severe diaper rash.
The report found that mothers struggling with diaper needs miss school and work more frequently or they keep their child out of day care, which usually requires a day’s supply of diapers. In the report, one mother said, “Having a clean diaper not only keeps their child healthy and well, but lets them know that they’re cared for. I think it would be great if food banks and soup kitchens offered diapers also to those in need.”
Other major Weis Little Ones sponsors include Johnson’s, Weis Bear Essentials and Aveno Baby. Over the next six weeks, customers can purchase diapers, baby wipes, baby lotions, rattles or baby toys, baby shampoos, teethers, baby detergent and bibs or burp clothes, and can place them in designated donation carts.
APMA recommends Health Enterprises product for runners
BETHESDA, Md. The American Podiatric Medical Association recently issued a series of recommendations for runners, including the use of a self-massager designed for post-athletic activities. Specifically, the association recommended Health Enterprises’ therapeutic hot-and-cold foot massager, a product that carries the APMA seal of approval.
"Some of the most common running-related foot injuries that today’s podiatrists treat are arch pain, tendonitis and blisters," stated APMA president Kathleen Stone. “However, if runners can take just a few minutes to stretch properly pre-workout, select appropriate footwear and see a podiatrist immediately when foot pain occurs, many of these ailments can be avoided entirely.”
Other recommendations made by APMA included selecting a good running shoe, selecting good socks and stretching for five to 10 minutes prior to a run. Frequent runners should see a podiatrist on a regular basis to maximize any running program and prevent serious injury, the association added.
CVS Caremark announces settlement of PSE sales suit
WOONSOCKET, R.I. Under a settlement reached with the Drug Enforcement Administration and the U.S. Attorneys’ Offices for the Central District of California and the District of Nevada, CVS Caremark has agreed to pay $75 million in civil penalties and $2.6 million in profit forfeitures to settle allegations that in 2007 and 2008, certain CVS/pharmacy stores in California and Nevada engaged in unlawful sales of pseudoephedrine.
CVS also must maintain certain compliance measures to monitor and prevent excessive sales of the ingredient found in popular over-the-counter cold-cough medicines. In addition, the settlement acknowledged that a distribution center in California failed to monitor and report excessive PSE sales by CVS/pharmacy stores; it related only to the retail pharmacy business.
“We are announcing today that we have resolved this issue, which unfortunately resulted from a breakdown in CVS/pharmacy’s normally high management and oversight standards,” stated Tom Ryan, chairman and CEO of CVS Caremark. “While this lapse occurred in 2007 and 2008, and has been addressed, it was an unacceptable breach of the company’s policies and was totally inconsistent with our values. CVS/pharmacy is unwavering in its support of the measures taken by the federal government and the states to prevent drug abuse. To make certain this kind of lapse never takes place again,” Ryan continued, “we have strengthened our internal controls and compliance measures, and made substantial investments to improve our handling and monitoring of PSE by implementing enhanced technology and making other improvements in our stores and distribution centers.”
The settlement does not impact any other business conducted by CVS or any of its affiliated companies. In addition, the settlement amount has been fully reserved, as previously disclosed, and should have no further effect on the company’s financial results, the company stated.
The settlement related to excessive sales of PSE at certain CVS/pharmacy locations that resulted from the flawed implementation of an electronic monitoring system to record individual PSE sales. As implemented in California, Nevada and certain other states, the system did not prevent multiple sales of PSE that totaled more than the federal daily legal limit, which made certain CVS/pharmacy stores vulnerable to criminals who intended to purchase large amounts of PSE. The excessive sales occurred primarily in California and Nevada. The settlement includes not only federal jurisdictions in California and Nevada, but also federal jurisdictions in 23 other states where the system was not implemented properly, CVS stated.